HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jae-Hyun Park Selected Research

Polypeptide N-acetylgalactosaminyltransferase

10/2018Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
1/2017GALNT6 Stabilizes GRP78 Protein by O-glycosylation and Enhances its Activity to Suppress Apoptosis Under Stress Condition.
1/2016Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.
4/2010Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jae-Hyun Park Research Topics

Disease

57Neoplasms (Cancer)
11/2021 - 01/2003
19Breast Neoplasms (Breast Cancer)
01/2021 - 09/2006
9Carcinogenesis
02/2020 - 11/2004
7Colorectal Neoplasms (Colorectal Cancer)
03/2013 - 01/2003
6Stomach Neoplasms (Stomach Cancer)
08/2020 - 01/2004
6Squamous Cell Carcinoma of Head and Neck
04/2019 - 07/2016
5Microsatellite Instability
01/2018 - 01/2003
4Melanoma (Melanoma, Malignant)
12/2021 - 12/2014
4Ovarian Neoplasms (Ovarian Cancer)
11/2018 - 09/2002
4Cognitive Dysfunction
10/2016 - 05/2013
4Testicular Neoplasms (Testicular Cancer)
10/2009 - 09/2006
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 10/2021
3Autoimmune Diseases (Autoimmune Disease)
07/2018 - 01/2015
2Reperfusion Injury
01/2022 - 10/2021
2Ischemia
11/2021 - 10/2021
2Obesity
10/2021 - 01/2015
2Myocardial Infarction
01/2020 - 01/2019
2Residual Neoplasm
01/2019 - 01/2018
2Triple Negative Breast Neoplasms
04/2018 - 10/2014
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2017 - 03/2016
2Kidney Neoplasms (Kidney Cancer)
01/2017 - 04/2016
2Cerebral Small Vessel Diseases
10/2016 - 02/2015
2Alzheimer Disease (Alzheimer's Disease)
02/2015 - 05/2013
1Inflammation (Inflammations)
01/2022
1Cardiac Edema
01/2022
1Edema (Dropsy)
01/2022
1Heart Failure
11/2021
1Fibrosis (Cirrhosis)
10/2021
1Pleurisy (Pleuritis)
01/2021
1Acquired Immunodeficiency Syndrome (AIDS)
08/2020
1Multiple Myeloma
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Neuroblastoma
01/2019
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2018
1Food Hypersensitivity (Food Allergy)
07/2018
1Communicable Diseases (Infectious Diseases)
07/2018

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2002
13Small Interfering RNA (siRNA)IBA
02/2020 - 01/2007
12Phosphotransferases (Kinase)IBA
01/2020 - 09/2006
9Pharmaceutical PreparationsIBA
11/2021 - 01/2004
9T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2018 - 11/2015
8Protein Kinases (Protein Kinase)IBA
01/2020 - 02/2010
6Biological ProductsIBA
02/2020 - 01/2003
6DNA (Deoxyribonucleic Acid)IBA
01/2019 - 01/2003
6OligonucleotidesIBA
09/2004 - 02/2002
5OTS167IBA
04/2019 - 03/2016
5Immune Checkpoint InhibitorsIBA
11/2018 - 01/2016
5AntigensIBA
09/2017 - 09/2006
4Polypeptide N-acetylgalactosaminyltransferaseIBA
10/2018 - 04/2010
4Amyloid (Amyloid Fibrils)IBA
10/2016 - 05/2013
4Cadherins (E-Cadherin)IBA
01/2016 - 06/2004
3Peptides (Polypeptides)IBA
01/2021 - 10/2018
3Histones (Histone)IBA
08/2018 - 07/2004
3HLA-A Antigens (HLA-A)IBA
02/2018 - 01/2016
3Messenger RNA (mRNA)IBA
08/2017 - 05/2015
3GlycosyltransferasesIBA
01/2017 - 04/2010
3Codon (Codons)IBA
09/2005 - 02/2002
2Peptide Hydrolases (Proteases)FDA Link
11/2021 - 05/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 11/2020
2IronIBA
10/2021 - 01/2009
2Biomarkers (Surrogate Marker)IBA
02/2020 - 01/2018
2Glycoproteins (Glycoprotein)IBA
02/2020 - 04/2010
2OTS964IBA
01/2020 - 12/2016
2PDZ-binding kinaseIBA
01/2020 - 09/2006
2Estrogen Receptor alphaIBA
10/2018 - 08/2009
2Doxorubicin (Adriamycin)FDA LinkGeneric
08/2018 - 01/2004
2durvalumabIBA
04/2018 - 01/2018
2OTS514IBA
12/2016 - 04/2016
2NivolumabIBA
07/2016 - 01/2016
2MucinsIBA
01/2016 - 04/2010
2Mucin-1 (CA 15-3 Antigen)IBA
01/2016 - 04/2010
25- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA
02/2015 - 05/2013
2Indicators and Reagents (Reagents)IBA
11/2012 - 01/2006
2Paclitaxel (Taxol)FDA LinkGeneric
01/2011 - 01/2009
2beta CateninIBA
04/2010 - 08/2003
2Cisplatin (Platino)FDA LinkGeneric
04/2004 - 01/2004
1CU06-1004IBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021
1salicylhydroxamic acid (SHAM)IBA
10/2021
1histochromeIBA
10/2021
1Galla RhoisIBA
10/2021
1NucleotidesIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1NADPH Oxidases (NAD(P)H oxidase)IBA
11/2020
1Circulating Tumor DNAIBA
08/2020
1LectinsIBA
02/2020
1Carrier Proteins (Binding Protein)IBA
02/2020
1Alemtuzumab (Campath)FDA Link
01/2020
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2020
1Lenalidomide (CC 5013)FDA Link
10/2018
1Lysine (L-Lysine)FDA Link
08/2018
1Protein MethyltransferasesIBA
08/2018
1Immune Checkpoint ProteinsIBA
07/2018

Therapy/Procedure

15Therapeutics
01/2019 - 09/2006
6Drug Therapy (Chemotherapy)
01/2019 - 01/2011
5Immunotherapy
01/2019 - 01/2016
3Aftercare (After-Treatment)
08/2020 - 01/2017
2Chemoradiotherapy
08/2017 - 09/2007
2Acupuncture Points (Acupuncture Point)
01/2009 - 01/2009
1Intravenous Injections
10/2021